Clinical Trial Update: Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety of KetoNaph ophthalmic solution in healthy volunteers for allergic conjunctivitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• KetoNaph ophthalmic solution (KetoNaph ophthalmic solution)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2020-09-14